1. Home
  2. IPWR vs ADVM Comparison

IPWR vs ADVM Comparison

Compare IPWR & ADVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPWR
  • ADVM
  • Stock Information
  • Founded
  • IPWR 2007
  • ADVM 2006
  • Country
  • IPWR United States
  • ADVM United States
  • Employees
  • IPWR N/A
  • ADVM N/A
  • Industry
  • IPWR Industrial Machinery/Components
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • IPWR Industrials
  • ADVM Health Care
  • Exchange
  • IPWR Nasdaq
  • ADVM Nasdaq
  • Market Cap
  • IPWR 52.8M
  • ADVM 47.4M
  • IPO Year
  • IPWR 2013
  • ADVM 2014
  • Fundamental
  • Price
  • IPWR $5.73
  • ADVM $2.70
  • Analyst Decision
  • IPWR Hold
  • ADVM Strong Buy
  • Analyst Count
  • IPWR 1
  • ADVM 5
  • Target Price
  • IPWR N/A
  • ADVM $23.80
  • AVG Volume (30 Days)
  • IPWR 40.7K
  • ADVM 277.9K
  • Earning Date
  • IPWR 08-13-2025
  • ADVM 08-11-2025
  • Dividend Yield
  • IPWR N/A
  • ADVM N/A
  • EPS Growth
  • IPWR N/A
  • ADVM N/A
  • EPS
  • IPWR N/A
  • ADVM N/A
  • Revenue
  • IPWR $19,296.00
  • ADVM $1,000,000.00
  • Revenue This Year
  • IPWR N/A
  • ADVM N/A
  • Revenue Next Year
  • IPWR $5,900.00
  • ADVM $18.82
  • P/E Ratio
  • IPWR N/A
  • ADVM N/A
  • Revenue Growth
  • IPWR N/A
  • ADVM N/A
  • 52 Week Low
  • IPWR $3.77
  • ADVM $1.78
  • 52 Week High
  • IPWR $9.69
  • ADVM $8.58
  • Technical
  • Relative Strength Index (RSI)
  • IPWR 56.10
  • ADVM 54.36
  • Support Level
  • IPWR $5.65
  • ADVM $2.57
  • Resistance Level
  • IPWR $6.27
  • ADVM $2.85
  • Average True Range (ATR)
  • IPWR 0.55
  • ADVM 0.21
  • MACD
  • IPWR -0.00
  • ADVM 0.02
  • Stochastic Oscillator
  • IPWR 53.17
  • ADVM 62.42

About IPWR Ideal Power Inc.

Ideal Power Inc is pioneering the development of its broadly patented bidirectional power switches, creating efficient and ecofriendly energy control solutions for electric vehicles, electric vehicle charging, renewable energy, energy storage, UPS / data center, solid-state circuit breaker and other industrial and military applications. The company is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN) semiconductor technology. B-TRAN is a double-sided bidirectional AC switchable to deliver substantial performance improvements over conventional power semiconductors. The primary raw material used in the fabrication of B-TRAN devices is silicon wafers.

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

Share on Social Networks: